Arbovirus Infections clinical trials
The registry lists 21 studies for Arbovirus Infections across more than 10 countries. 6 are recruiting or about to start. 7 of them are mainly about Arbovirus Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-04-22. Counting its 7 narrower conditions too, such as Dengue: 572 studies, 81 open.
Get an email when these change. Save the Arbovirus Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Institut Pasteur (4) · Emergent BioSolutions (2) · U.S. Army Medical Research and Development Command (2) · University of Notre Dame (2) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · University Hospital, Strasbourg, France (1) · Institute of Tropical Medicine, Belgium (1) · Johns Hopkins University (1)
What is being tested here
Drugs under test in Arbovirus Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Dexamethasone | 1 | 1 | 1 |
| Acetylcysteine | 1 | 1 | 1 |
| Baricitinib | 1 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026ARBOspot: Characterization of Arbovirus Specific T Cell Response in Patients by Using Enzyme Linked Immunospot (ELISpot) Assays · Fondazione IRCCS Policlinico San Matteo di Pavia
- Dec 2026Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility · Institute of Tropical Medicine, Belgium
Who these studies take
Of the 4 Arbovirus Infections studies recruiting now, 4 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (50%) | 2 (50%) |
| 18 | 4 (100%) | 4 (100%) |
| 30 | 4 (100%) | 4 (100%) |
| 40 | 4 (100%) | 4 (100%) |
| 50 | 4 (100%) | 4 (100%) |
| 65 | 4 (100%) | 4 (100%) |
| 75 | 4 (100%) | 4 (100%) |
| 85 | 4 (100%) | 4 (100%) |
Across all 21 studies, recruiting or not: 24% stop at 75 or younger and 14% at 65; 57% take children; 5% are for women only and 0% for men only; 71% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 21 of 21. search them.
- Therapeutics for Moderate and Severe DengueNot yet recruitingNCT07543458Phase 310 countries
- ARBOspot: Characterization of Arbovirus Specific T Cell Response in Patients by Using Enzyme Linked Immunospot (ELISpot) AssaysRecruitingNCT072912061 country
- "Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"Not yet recruitingNCT074129771 country
- Cohort Study of Arbovirus and Other Emerging Virus Infections in Fiji: AEVI-Fiji Cohort.RecruitingNCT072296771 country
- Virological and Immunological Determinants of Arbovirus Infection in New CaledoniaRecruitingNCT04619823Not applicable1 country
- Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of WolbachiaRecruitingNCT046153641 country
- Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human MobilityActive, not recruitingNCT065999701 country
- Spatial Repellents for Aedes-borne Virus Control in Sri LankaCompletedNCT05452447Not applicable1 country
- The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return TravelersActive, not recruitingNCT066513721 country
- Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal CoatingCompletedNCT06268691Not applicable2 countries
- Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy SubjectsCompletedNCT02061358Phase 11 country
- Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy SubjectsTerminatedNCT02696291Phase 11 country
- Safety and Immunogenicity Study of Rift Valley Fever Vaccine, InactivatedCompletedNCT00869713Phase 21 country
- World Mosquito Program Noumea - Human Sample ComponentStatus unknownNCT035520941 country
- Human Epidemiology of Newly Identified ArbovirusesStatus unknownNCT049543521 country
- Spatial Repellents for Arbovirus ControlCompletedNCT03553277Not applicable1 country
- Sero-epidemiology of Priority Arboviruses in French GuianaCompletedNCT03210363Not applicable1 country
- Neurologic Manifestations of the Arbovirus Infection in ColombiaCompletedNCT032065411 country
- Safety and Immunogenicity Study of Rift Valley Fever VaccineCompletedNCT00584194Phase 21 country
- Pilot Survey of Dengue Fever in Solomon IslandsCompletedNCT018683991 country
- Field Evaluation of Plant-based Mosquito ControlCompletedNCT00116766Phase 2